EA can reduce the formation of cofilin rod and the degradation of MAP2, inhibit the cleavage of mitochondrial cofilin and caspase-3, significantly reduce the apoptosis and loss of neurons after ischemic stroke, thus enhancing the recovery of nerve function and reducing brain injury and infarct volume. The gene discussed is CASP3; the disease is ischemic stroke.